Key terms
About HRTX
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HRTX news
Apr 23
8:25am ET
Heron Therapeutics management to meet virtually with Northland
Apr 23
6:54am ET
Heron Therapeutics initiated with an Overweight at Capital One
Apr 23
4:55am ET
Heron Therapeutics management to meet virtually with Northland
Apr 16
1:50pm ET
Heron Therapeutics management to meet virtually with Northland
Apr 16
4:55am ET
Heron Therapeutics management to meet virtually with Northland
Apr 10
4:25pm ET
Heron Therapeutics management to meet virtually with Northland
Mar 21
4:42pm ET
Heron Therapeutics Announces New Principal Accounting Officer
Mar 15
11:32am ET
Biotech Alert: Searches spiking for these stocks today
Mar 13
9:41am ET
Heron Therapeutics price target raised to $5 from $4 at Needham
Mar 13
8:56am ET
Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)
Mar 13
6:17am ET
Heron Therapeutics: A Strong Buy on Robust Q4 Performance and Promising Revenue Growth Prospects
Mar 12
4:11pm ET
Heron Therapeutics sees FY24 Adjusted EBITDA ($22.0M)-$3.0M
Mar 12
4:08pm ET
Heron Therapeutics reports Q4 EPS (7c), consensus (16c)
Mar 12
2:19pm ET
Heron Therapeutics options imply 11.6% move in share price post-earnings
Mar 12
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 12, 2024
Jan 26
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 25
11:38am ET
Biotech Alert: Searches spiking for these stocks today
Jan 25
11:38am ET
Biotech Alert: Searches spiking for these stocks today
Jan 25
4:07am ET
Heron Therapeutics Gains FDA Nod for ZYNRELEF® Expansion
No recent press releases are available for HRTX
HRTX Financials
Key terms
Ad Feedback
HRTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HRTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range